SMI-4a
A selective, ATP-competitive inhibitor Pim-1 (IC₅₀ = 21 nM) and Pim-2 (IC₅₀ = 100 nM) protein kinases. Blocks mTORC1 activity via activation of AMPK. SMI-4a has been found to inhibit prostate cancer cell growth and induce G1 phase cell-cycle arrest in precursor T-cell lymphoblastic leukemia/lymphoma cell lines.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
24months
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog